Veltuzumab Uses, Dosage, Side Effects and more
Veltuzumab is a monoclonal antibody which, as of October 2009, is undergoing Phase I/II clinical trials for the treatment of non-Hodgkin's lymphoma.
| Attribute | Details |
|---|---|
| Trade Name | Veltuzumab |
| Generic | Veltuzumab |
| Veltuzumab Other Names | Veltuzumab |
| Type | |
| Formula | C6458H9918N1706O2026S46 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in lymphoma (non-hodgkin's).
